The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10 mg rectal suppository every other day improves bowel-related symptoms in patients with multiple sclerosis. Patients will be randomized to receive either a placebo suppository or bisacodyl suppository dosed every other day for 4 weeks.
|Study Type :
||Interventional (Clinical Trial)
|Estimated Enrollment :
||Triple (Participant, Care Provider, Investigator)
||Treating Anorectal Dysfunction Associated With Multiple Sclerosis
|Study Start Date :
|Estimated Primary Completion Date :
|Estimated Study Completion Date :
David J Levinthal, MD, PhD 412-303-0525 email@example.com
For enrollment please visit www.clinicaltrials.gov.